Photocure ASA

Photocure ASA: Chairperson Bente-Lill Romøren not candidate for re-election

Oslo, Norway, 23 January 2017: Photocure ASA announces

today that Chairperson of the Board of Directors,

Bente-Lill Romøren, has informed the Nomination

Committee that due to other assignments she will not

be a candidate for re-election when her tenure expires

at the 2017 Annual General Meeting.

For further information, please contact:

Photocure

President & CEO Kjetil Hestdal

Tel: + 47 913 19 535

Notes to editors

About Photocure ASA

Photocure, headquartered in Oslo Norway, is a

specialty pharmaceutical company and world leader in

photodynamic technology. Based on our unique

proprietary Photocure Technology(TM) platform,

Photocure develops and commercializes highly selective

and effective solutions within disease areas with high

unmet medical need, such as bladder cancer, HPV and

precancerous cervical lesions, colorectal cancer and

skin conditions. Our aim is to provide solutions which

can improve health outcomes for patients worldwide.

Photocure is listed on the Oslo Stock Exchange (OSE:

PHO). Information about Photocure is available at

AI Terminal